Geron Cleared to Test Embryonic Stem-Cell Therapy
Geron Corp. said U.S. regulators cleared the company to proceed with the first medical trial of embryonic stem-cell treatment in patients with spinal-cord injuries. The shares rose as much as 16 percent.